Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55+
SponsorImelda Hospital, Bonheiden

About this trial

Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.

Eligibility criteria

Qualifiers

Age 65 years and older

Disqualifiers

known haematological condition (myelodysplasia, leukemia, cancer)

inability to provide written informed consent

Trial design

Treatments tested in this trial

  • Blood and bone marrow cell collection

Treatment groups

24 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Imelda Hospital, Bonheiden

Lead sponsor

Université Catholique de Louvain

Collaborator